Vetter’s Newest Facility Successfully Completes FDA Inspection
News Mar 28, 2013
Vetter has announced that its new center for visual inspection and logistics passed its first GMP inspection by the U.S. Food and Drug Administration (FDA).
The inspection was conducted March 11 through 14 to ensure the facility is in compliance with good manufacturing practices.
The facility was already granted manufacturing approval and cGMP certification for Europa from the RP Tuebingen, Germany in 2012.
The 18,000-square-meter facility, known as Ravensburg Vetter West (RVW), began operations in April 2012.
The site provides high-bay warehousing for cold storage and room-temperature products, as well as visual inspection.
Featuring technology, which helps adapted to the needs of the separate supply and manufacturing processes, RVW also harnesses extensive use of renewable energy sources, including photovoltaic and geothermal.
“We’re pleased with the outcome of Ravensburg Vetter West’s first FDA GMP inspection,” said managing director Thomas Otto.
Otto continued, “We at Vetter work diligently to meet regulatory requirements. Maintaining high quality standards is a job we take seriously to be a reliable and efficient partner for our customers.”
SYGNIS AG Announces Completion of Relocation of its Innova Biosciences UnitNews
Move forms part of integration into SYGNIS Group.READ MORE
Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to TreatmentNews
Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.READ MORE
Comments | 0 ADD COMMENT
Annual Conference on Antimicrobials and Drug Resistance
Sep 24 - Sep 25, 2018
1st Alpine Winter Conference on Medicinal and Synthetic Chemistry
Jan 28 - Feb 01, 2018